351
|
Zhang Y, Wei X, Bajaj G, Barrett JS, Meibohm B, Joshi A, Gupta M. Challenges and considerations for development of therapeutic proteins in pediatric patients. J Clin Pharmacol 2015; 55 Suppl 3:S103-15. [PMID: 25707958 DOI: 10.1002/jcph.382] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2014] [Accepted: 08/13/2014] [Indexed: 11/10/2022]
Abstract
Target specificity and generally good tolerability of therapeutic proteins (TPs) present desirable treatment opportunities for pediatric patients. However, little is known on the ontogeny of processes related to the pharmacokinetics (PK) and disposition of TPs. The science, regulatory requirements and strategy of developing TPs for children are evolving. Our current review of TPs, (with focus on monoclonal antibodies and fusion proteins) that were approved for pediatric use indicates that dose-selection for pediatric pivotal studies is often based on adult PK information alone. This approach might not be sufficient if more complex PK properties than simple linear PK are present. Body weight-based dosing for pediatric patients directly scaled down from adult dosing can lead to under-exposure in young pediatric patients who are usually in the lowest body-weight range. Tiered-fixed dosing can be reasonably effective for TPs in achieving comparable exposure in children over a wide age range. The uniqueness of the pediatric population, the practical challenges in conducting clinical studies in this population, as well as regulations from health authorities warrant including pharmacometrics as an integral component of pediatric drug development. We propose a framework distinct from previous proposals, to guide clinical pharmacology strategy for pediatric drug development specifically for TPs.
Collapse
|
352
|
Farooqi A, Holliday E, Allen P, Wei X, Komaki R. Factors Influencing Brain Recurrence and Survival Among Patients With Limited-Stage Small Cell Lung Cancer After Complete Response to Treatment. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
353
|
Wei X, Allen P, Erasmus J, Blumenschein G, Godoy M, Lee J, O'Reilly M, Welsh J, Cox J, Hong W, Komaki R. PET Metabolic Tumor Response by PERCIST Reliably Predicts Local Regional Control in Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy With Erlotinib. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
354
|
Wei X, Komaki R, Choi N, O'Reilly M, Fossella F, Chang J, Gomez D, Nguyen Q, Pisters K, Tsao A, Massarelli E, Zhuang Y, Xu T, Hernandez M, Mohan R, Liao Z. Radiation Dose-Escalation to the Gross Tumor Volume Using Simultaneous Integrated Boost Intensity Modulated Photon or Proton Therapy With Concurrent Chemotherapy for Stage II-III Non-Small Cell Lung Cancer: A Preliminary Report of a Phase 1 Protocol. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
355
|
Komaki R, Wei X, Allen P, Holliday E, Farooqi A, Lin S, Balter P, Mohan R, Liao Z, Cox J. Factors Associated With Severe Pneumonitis for Limited Stage Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1658] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
356
|
Booth CM, Nanji S, Wei X, Biagi JJ, Krzyzanowska MK, Mackillop WJ. Surgical resection and peri-operative chemotherapy for colorectal cancer liver metastases: A population-based study. Eur J Surg Oncol 2015; 42:281-7. [PMID: 26558526 DOI: 10.1016/j.ejso.2015.10.006] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2015] [Revised: 10/06/2015] [Accepted: 10/16/2015] [Indexed: 10/22/2022] Open
Abstract
BACKGROUND Most literature describing surgery for colorectal cancer (CRC) liver metastases (LM) comes from high volume centres. Here, we report management and outcomes achieved in routine clinical practice. METHODS All cases of CRC in Ontario who underwent resection of LM in 1994-2009 were identified using the population-based Ontario Cancer Registry. Electronic treatment records identified chemotherapy delivery. Temporal trends are described for 3 periods: 1994-1999, 2000-2004, 2005-2009. We describe volume of resected CRCLM as a ratio of incident cases per CRCLM resection. Overall (OS) and cancer-specific survival (CSS) are measured from time of LM resection. RESULTS 2717 patients underwent resection of CRCLM. Between 1994 and 2009 there was a 78% increase in case volume; from one resection for every 48 incident cases to one resection for every 27 incident cases, p < 0.001. Use of peri-operative chemotherapy increased over study periods from 44% (306/700), to 52% (429/830), to 65% (777/1187, p < 0.001). Chemotherapy utilization rates varied across geographic regions (range 43%-69%, p < 0.001). Post-operative mortality rates at 30 and 90 days were 2.5% and 4.3% respectively. Five year OS during the study periods was 36% (95% CI 32-39%), 40% (95% CI 36-43%), and 46% (95% CI 43-49%) (p < 0.001); CSS was 38% (95% CI 35-42%), 42% (95% CI 38-45%), 49% (95% CI 44-53%) (p < 0.001). The temporal improvement in OS/CSS persisted on adjusted analyses. CONCLUSIONS Outcomes of patients with resected CRCLM in routine practice is comparable to those reported from high volume centres. Survival improved over the study period despite a greater proportion of patients with CRC undergoing liver resection.
Collapse
|
357
|
Ren G, Sun A, Deng C, Zhang J, Wu X, Wei X, Mani S, Dou W, Wang Z. The anti-inflammatory effect and potential mechanism of cardamonin in DSS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2015; 309:G517-27. [PMID: 26251468 PMCID: PMC4593824 DOI: 10.1152/ajpgi.00133.2015] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2015] [Accepted: 07/26/2015] [Indexed: 01/31/2023]
Abstract
Cardamonin is a naturally occurring chalcone with strong anti-inflammatory activity. However, the direct effect of cardamonin on intestinal inflammation remains elusive. In the present study, we found that cardamonin markedly ameliorated dextran sulfate sodium-induced mouse body weight loss, diarrhea, colon shortening, spleen swelling, and histological damage, which correlated with a decline in the activity of myeloperoxidase and the production of nitric oxide, tumor necrosis factor-α and interleukin-6 in the colon. The upregulation of toll-like receptor 4 after dextran sulfate sodium treatment was associated with an increase in the activation of myeloid differentiation factor 88, interleukin-1 receptor-associated kinase-1, nuclear factor-κB (NF-κB) p65, inhibitor κBα, and inhibitor κB kinase-α/β, as well as the mitogen-activated protein kinase molecules of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase, and this upregulation was reversed by cardamonin administration. Moreover, cardamonin blocked the nuclear translocation of NF-κB p65, inhibited NF-κB-luciferase activity, and downregulated NF-κB target genes expression. The present study clearly demonstrates a beneficial effect of cardamonin on experimental inflammatory bowel disease via a mechanism associated with suppression of toll-like receptor 4 expression and inactivation of NF-κB and mitogen-activated protein kinase pathways. This study may give insight into the further evaluation of the therapeutic potential of cardamonin or its derivatives for human inflammatory bowel disease.
Collapse
|
358
|
Huang JS, Wu Y, Huang Q, Li SJ, Ye JM, Wei X, Liu QD, Liu Y, Ma MG. Expression level and distribution of HMGB1 in Sombati's cell model and kainic acid-induced epilepsy model. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2015; 19:2928-2933. [PMID: 26241550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE Observe the expression and distribution of HMGB1 in Sombati's cell model and kainic acid-induced epileptic rats' model. MATERIALS AND METHODS Dissociated hippocampal neurons from neonatal SD rats and cultured those for 9 days, then changed medium to Mg2+-free medium for 3 hours to induce Sombati's cell model. The expression level of HMGB1 in the neurons was detected at 24h and 72h by Western Blotting. Appropriate kainic acid was injected into the lateral ventricles to induced epileptic rats' model in vivo trial, the expression level and distribution of HMGB1 at 24h and 72h were established by immunohistochemistry. RESULTS The expression level of HMGB1 showed significantly different between model group and control group both in vitro and in vivo trials. At 24h, the expression level of HMGB1 in the model group was lower than the control group (p < 0.05), and became higher than the control group at 72h (p < 0.05). From the in vivotrial, a nucleus-to-cytoplasm translocation was also discovered. CONCLUSIONS This investigation indicates that HMGB1 plays a crucial role in the pathophysiology of epilepsy, by altering its quantity and distribution.
Collapse
|
359
|
Hou L, Li W, Wei X, Zhou Y, Zhuo Y, Wu H, Shen B. Immune memory responses to HBV vaccine 13-18 years after primary vaccination. GENETICS AND MOLECULAR RESEARCH 2015; 14:8466-72. [PMID: 26345774 DOI: 10.4238/2015.july.28.14] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The aim of this study was to evaluate the immune memory response 13-18 years after an hepatitis B virus (HBV) vaccine by performing a specific in vitro stimulation experiment. Thirty healthy volunteers who had been inoculated 13-18 years ago with the HBV vaccine were collected from the physical examination center. Peripheral blood mononuclear cells were stimulated with 50 ng/mL recombinant HBsAg. An ELISA kit was used for the detection of antibodies that were produced by these cells in vitro. It was found that even 13-18 years after inoculation with the HBV vaccine, an anamnestic antibody response still existed, and was not correlated with the serum antibody levels (r = -0.177, P = 0.377). In conclusion, our data showed that the individuals after inoculation, including those with anti-HBs <10 IU/L as well as those individuals in whom the antibody was not detected, retained immune memory, which may be the main role of memory B cells.
Collapse
|
360
|
Wang H, Ji J, Yu Y, Wei X, Chai S, Liu D, Huang D, Li Q, Dong Z, Xiao X. Neonatal Overfeeding in Female Mice Predisposes the Development of Obesity in their Male Offspring via Altered Central Leptin Signalling. J Neuroendocrinol 2015; 27:600-8. [PMID: 25855235 DOI: 10.1111/jne.12281] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/25/2014] [Revised: 03/15/2015] [Accepted: 03/31/2015] [Indexed: 02/01/2023]
Abstract
The prevalence of obesity among child-bearing women has increased significantly. The adverse consequences of maternal obesity on the descendants have been well accepted, although few studies have examined the underlying mechanisms. We investigated whether neonatal overfeeding in female mice alters metabolic phenotypes in the offspring and whether hypothalamic leptin signalling is involved. Neonatal overfeeding was induced by reducing the litter size to three pups per litter, in contrast to normal litter size of 10 pups per litter. Normal and neonatally overfed female mice were bred with normal male mice, and offspring of overfeeding mothers (OOM) and control mothers (OCM) were generated. We examined body weight, daily food intake, leptin responsiveness and the number of positive neurones for phosphorylated-signal transducer and activator of transcription 3 (pSTAT3) along with neuropeptide Y (NPY) in the arcuate nucleus of the hypothalamus (ARH) and NPY in the nucleus tractus solitarius (NTS) of the brain stem. The body weight and daily food intake of OOM were significantly higher than those of OCM. Leptin significantly reduced food intake and increased the number of pSTAT3 positive neurones in the ARH of OCM mice, whereas no significant changes in food intake and pSTAT3 neurones were found in leptin-treated OOM mice. The number of NPY neurones in the ARH and NTS of the OOM mice was significantly higher than that of OCM mice. The results of the present study indicate that the obese phenotype from mothers can be passed onto the subsequent generation, which is possibly associated with hypothalamic leptin resistance.
Collapse
|
361
|
Cao Z, Mu F, Wei X, Sun Y. Influence of CO2-induced seawater acidification on the development and lifetime reproduction ofTigriopus japonicusMori, 1938. J NAT HIST 2015. [DOI: 10.1080/00222933.2015.1034213] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
362
|
Yuan L, Wei X, Xu C, Jin Y, Wang G, Li Y, Tian H, Chen S. Use of multisequence 3.0-T MRI to detect severe traumatic brain injury and predict the outcome. Br J Radiol 2015; 88:20150129. [PMID: 26067919 DOI: 10.1259/bjr.20150129] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVE The aim of this study was to evaluate multisequence 3.0-T MRI in the detection of severe traumatic brain injury (sTBI) and in predicting the outcome. METHODS 32 patients with sTBI were prospectively enrolled, and multisequence 3.0-T MRI was performed 4-8 weeks post injury. Quantitative data were recorded on each sequence. The ability to display the parenchymal lesions was compared with that of 64-slice spiral CT. The clinical and radiological results were correlated with the Glasgow Outcome Scale Extended scores 6 months after injury. RESULTS 3.0-T MRI could display more lesions than CT, especially when the lesion was deeply located. The lesion volumes and diffuse axonal injury (DAI) scores were different between good and poor outcome groups on fluid attenuated inversion recovery (p < 0.05). The apparent diffusion coefficient (ADC) values of the splenium of the corpus callosum and brain stem were also different (p < 0.05). Patients with unfavourable outcome showed a significantly higher volume of haemorrhage on susceptibility-weighted imaging than those with favourable outcomes and had haemorrhages generally located more deeply. Logistic regression analysis revealed that the location of haemorrhage and the ADC values of the splenium of the corpus callosum were independent risk factors for poor outcome, with an overall predictive accuracy of 91.4%. CONCLUSION The joint use of conventional and advanced sequences of 3.0-T MRI can comprehensively detect the pathological changes occurring after sTBI. Haemorrhagic and non-haemorrhagic DAIs in deep structures strongly suggest poor outcome. ADVANCES IN KNOWLEDGE This article improves the understanding of advanced MRI sequences in the detection of patients with sTBI and prediction of prognosis.
Collapse
|
363
|
Wei X, Yin H. Covalent modification of DNA by α, β-unsaturated aldehydes derived from lipid peroxidation: Recent progress and challenges. Free Radic Res 2015; 49:905-17. [PMID: 25968945 DOI: 10.3109/10715762.2015.1040009] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Oxidative stress-induced lipid peroxidation (LPO) has been associated with human physiology and pathophysiology. LPO generates an array of oxidation products and among them reactive lipid aldehydes have received intensive research attentions due to their roles in modulating functions of biomolecules through covalent modification. Thus, covalent modification of DNA by these reactive lipid electrophiles has been postulated to be partially responsible for the biological roles of LPO. In this review, we summarized recent progress and challenges in studying the roles of covalent modification of DNA including nuclear and mitochondrial DNA by reactive lipid metabolites from LPO. We focused on the novel mechanistic insights into generation of lipid aldehydes from cellular membranes especially mitochondria through LPO. Recent advances in the technological front using mass spectrometry have also been highlighted in the settings of studying DNA damage caused by LPO and its biological relevance.
Collapse
|
364
|
Kalunian KC, Merrill JT, Maciuca R, McBride JM, Townsend MJ, Wei X, Davis JC, Kennedy WP. A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE). Ann Rheum Dis 2015; 75:196-202. [PMID: 26038091 DOI: 10.1136/annrheumdis-2014-206090] [Citation(s) in RCA: 241] [Impact Index Per Article: 26.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2014] [Accepted: 03/22/2015] [Indexed: 01/01/2023]
Abstract
OBJECTIVES To examine the safety and efficacy of rontalizumab, a humanised IgG1 anti-interferon α (anti-IFN-α) monoclonal antibody, in patients with moderate-to-severe systemic lupus erythematosus (SLE). METHODS Patients with active SLE were randomised (2:1) to 750 mg intravenous rontalizumab every 4 weeks or placebo (Part 1), and 300 mg subcutaneous rontalizumab every 2 weeks or placebo (Part 2). BACKGROUND Hydroxychloroquine and corticosteroids were allowed. Patients taking immunosuppressants at baseline were required per protocol to discontinue. Efficacy end points included reduction in disease activity by British Isles Lupus Disease Activity Group (BILAG)-2004 (primary), and SLE response index (SRI, secondary) at Week 24. Efficacy was also examined by an exploratory measure of IFN-regulated gene expression (interferon signature metric, ISM). RESULTS Patients (n=238) received rontalizumab (n=159) or placebo (n=79). At baseline, the mean Safety of Estrogens in Lupus Erythematosus National Assessment version of the SLE Disease Activity Index (SELENA-SLEDAI) score in all cohorts was ~10, and 75.6% of patients had a high ISM (ISM-High). Efficacy response rates by BILAG and SRI were similar between rontalizumab and placebo groups. However, in the exploratory subgroup of ISM-Low patients, SRI response was higher and steroid use was lower in the rontalizumab-treated patients. There was also a reduction in SELENA-SLEDAI flare index rates (HR 0.61, 0.46 to 0.81, p=0.004) in this subgroup. Adverse events were similar between placebo and rontalizumab groups. CONCLUSIONS The primary and secondary end points of this trial were not met in all patients or in patients with high ISM scores. In an exploratory analysis, rontalizumab treatment was associated with improvements in disease activity, reduced flares and decreased steroid use in patients with SLE with low ISM scores. TRIAL REGISTRATION NUMBER NCT00962832.
Collapse
|
365
|
Uziel Y, Brogan P, Hofer M, Kuemmerle-Deschner J, Lauwerys B, Speziale A, Abrams K, Leon K, Wei X, Laxer R, Lachmann H. THU0536 Efficacy and Post-Vaccination Antibody Titer Data in Children with Caps Aged 28 Days to 4 Years Treated with Canakinumab. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4434] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
366
|
John Zhang XC, Zhang GH, Wei X, Guan YH. Evaluation of cesium-137 conversion models and parameter sensitivity for erosion estimation. JOURNAL OF ENVIRONMENTAL QUALITY 2015; 44:789-802. [PMID: 26024259 DOI: 10.2134/jeq2014.09.0371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The Cs technique has been widely used to provide soil redistribution estimates since the 1970s. However, most Cs-conversion models remain theoretical and largely unvalidated. Our objectives were to validate the four widely used conversion models, examine model parameter sensitivity, and evaluate the potential of using kriging to improve soil redistribution estimation. Soil loss was measured from a 1.6-ha plot since 1978. Winter wheat ( L.) was grown primarily under conventional tillage. Soil samples in a 10-m grid were taken from the plot to estimate the Cs inventory. Soil redistribution rates were estimated using four models and were further interpolated using ordinary kriging. The parameter sensitivity analyses at the 95% confidence limits showed that reference inventory had the most impact on estimated water erosion, followed by particle size correction for erosion and tillage depth, with minimal impacts from mass depth, bulk density, and particle size correction for deposition. Compared with the measured water erosion, the relative errors of the mean net water erosion estimates across the entire plot without and with kriging were 28 and -17% for the proportional model (PM), 141 and 106% for the simplified mass balance model, 133 and 100% for the improved mass balance model (MBM2), and 109% for the extended MBM2 with tillage erosion (MBM3). Results indicated that the PM performed better than the mass balance models under the study conditions and that kriging improved mean soil redistribution estimates. However, the full potential of the MBM2 and MBM3 needs to be further evaluated under conditions where loss of newly deposited Cs exists.
Collapse
|
367
|
Wei X, Jang G, Roper DK. Spectrophotometric determination of tin(II) by redox reaction using 3,3′,5,5′-tetramethylbenzidine dihydrochloride and N-bromosuccinimide. JOURNAL OF ANALYTICAL CHEMISTRY 2015. [DOI: 10.1134/s1061934815050159] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
368
|
Boros-Majewska J, Turczyk Ł, Wei X, Milewski S, Williams DW. A novel in vitro assay for assessing efficacy and toxicity of antifungals using human leukaemic cells infected with Candida albicans. J Appl Microbiol 2015; 119:177-87. [PMID: 25845720 DOI: 10.1111/jam.12817] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Revised: 03/20/2015] [Accepted: 03/27/2015] [Indexed: 11/29/2022]
Abstract
AIMS This study describes a novel in vitro assay that simultaneously determines antifungal efficiency and host cell toxicity using suspensions of human leukaemic cells (HL-60) infected with Candida albicans. METHODS AND RESULTS The effect of Candida infection on host cell viability was evaluated by the microscopy of trypan blue-stained cells and lactate dehydrogenase (LDH) activity. The in vitro 'drug potency assay' utilized the Cell Counting Kit-8 and measured post-antifungal treatment viability of Candida-infected HL-60 cells and the ability of the antifungal treatment to prevent infection. LDH activity showed that 42% ± 4·0 and 85·3% ± 7·40 of HL-60 cells were killed following Candida infection at the multiplicity of infection (MOI) of 1 : 1 and 1 : 5, respectively. The antifungal nystatin (0·78-25 μmol l(-1) ) was found to inhibit C. albicans infection as seen by the significantly increased viability of HL-60 cells. Cytotoxicity of nystatin towards infected HL-60 cells was evident at higher concentrations and this was also confirmed by propidium iodide staining. CONCLUSIONS An assay using undisturbed cell suspension conditions was successfully developed for assessing the selectivity of the antifungal therapy in the host-Candida environment. SIGNIFICANCE AND IMPACT OF THE STUDY The assay employing Candida infection of host cell suspensions represents a promising method for testing interactions of antifungal compounds with both fungal and host cells.
Collapse
|
369
|
Al-Hussaini A, Xu R, Jones A, Owens D, Wei X. P7 Investigating the role of the novel cytokine IL-35 in the regulation of anti-tumour immunity against head and neck cancer. Oral Oncol 2015. [DOI: 10.1016/j.oraloncology.2015.02.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
370
|
Wei X, Wang C, Long Y, Wang S. The effect of spine on the bounding dynamic performance of legged system. Adv Robot 2015. [DOI: 10.1080/01691864.2015.1015442] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
371
|
Adikaram D, Rimal D, Weinstein LB, Raue B, Khetarpal P, Bennett RP, Arrington J, Brooks WK, Adhikari KP, Afanasev AV, Amaryan MJ, Anderson MD, Anefalos Pereira S, Avakian H, Ball J, Battaglieri M, Bedlinskiy I, Biselli AS, Bono J, Boiarinov S, Briscoe WJ, Burkert VD, Carman DS, Careccia S, Celentano A, Chandavar S, Charles G, Colaneri L, Cole PL, Contalbrigo M, Crede V, D'Angelo A, Dashyan N, De Vita R, De Sanctis E, Deur A, Djalali C, Dodge GE, Dupre R, Egiyan H, El Alaoui A, El Fassi L, Elouadrhiri L, Eugenio P, Fedotov G, Fegan S, Filippi A, Fleming JA, Fradi A, Garillon B, Gilfoyle GP, Giovanetti KL, Girod FX, Goetz JT, Gohn W, Golovatch E, Gothe RW, Griffioen KA, Guegan B, Guidal M, Guo L, Hafidi K, Hakobyan H, Hanretty C, Harrison N, Hattawy M, Hicks K, Holtrop M, Hughes SM, Hyde CE, Ilieva Y, Ireland DG, Ishkhanov BS, Jenkins D, Jiang H, Jo HS, Joo K, Joosten S, Kalantarians N, Keller D, Khandaker M, Kim A, Kim W, Klein A, Klein FJ, Koirala S, Kubarovsky V, Kuhn SE, Livingston K, Lu HY, MacGregor IJD, Markov N, Mattione P, Mayer M, McKinnon B, Mestayer MD, Meyer CA, Mirazita M, Mokeev V, Montgomery RA, Moody CI, Moutarde H, Movsisyan A, Camacho CM, Nadel-Turonski P, Niccolai S, Niculescu G, Osipenko M, Ostrovidov AI, Park K, Pasyuk E, Peña C, Pisano S, Pogorelko O, Price JW, Procureur S, Prok Y, Protopopescu D, Puckett AJR, Ripani M, Rizzo A, Rosner G, Rossi P, Roy P, Sabatié F, Salgado C, Schott D, Schumacher RA, Seder E, Sharabian YG, Simonyan A, Skorodumina I, Smith ES, Smith GD, Sober DI, Sokhan D, Sparveris N, Stepanyan S, Stoler P, Strauch S, Sytnik V, Taiuti M, Tian Y, Trivedi A, Ungaro M, Voskanyan H, Voutier E, Walford NK, Watts DP, Wei X, Wood MH, Zachariou N, Zana L, Zhang J, Zhao ZW, Zonta I. Towards a resolution of the proton form factor problem: new electron and positron scattering data. PHYSICAL REVIEW LETTERS 2015; 114:062003. [PMID: 25723209 DOI: 10.1103/physrevlett.114.062003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/25/2014] [Indexed: 06/04/2023]
Abstract
There is a significant discrepancy between the values of the proton electric form factor, G(E)(p), extracted using unpolarized and polarized electron scattering. Calculations predict that small two-photon exchange (TPE) contributions can significantly affect the extraction of G(E)(p) from the unpolarized electron-proton cross sections. We determined the TPE contribution by measuring the ratio of positron-proton to electron-proton elastic scattering cross sections using a simultaneous, tertiary electron-positron beam incident on a liquid hydrogen target and detecting the scattered particles in the Jefferson Lab CLAS detector. This novel technique allowed us to cover a wide range in virtual photon polarization (ϵ) and momentum transfer (Q(2)) simultaneously, as well as to cancel luminosity-related systematic errors. The cross section ratio increases with decreasing ϵ at Q(2)=1.45 GeV(2). This measurement is consistent with the size of the form factor discrepancy at Q(2)≈1.75 GeV(2) and with hadronic calculations including nucleon and Δ intermediate states, which have been shown to resolve the discrepancy up to 2-3 GeV(2).
Collapse
|
372
|
Seder E, Biselli A, Pisano S, Niccolai S, Smith GD, Joo K, Adhikari K, Amaryan MJ, Anderson MD, Anefalos Pereira S, Avakian H, Battaglieri M, Bedlinskiy I, Bono J, Boiarinov S, Bosted P, Briscoe W, Brock J, Brooks WK, Bültmann S, Burkert VD, Carman DS, Carlin C, Celentano A, Chandavar S, Charles G, Colaneri L, Cole PL, Contalbrigo M, Crabb D, Crede V, D'Angelo A, Dashyan N, De Vita R, De Sanctis E, Deur A, Djalali C, Doughty D, Dupre R, El Fassi L, Elouadrhiri L, Eugenio P, Fedotov G, Fegan S, Filippi A, Fleming JA, Fradi A, Garillon B, Garçon M, Gevorgyan N, Ghandilyan Y, Giovanetti KL, Girod FX, Goetz JT, Gohn W, Gothe RW, Griffioen KA, Guegan B, Guidal M, Guo L, Hafidi K, Hakobyan H, Hanretty C, Harrison N, Hattawy M, Hirlinger Saylor N, Holtrop M, Hughes SM, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Jo HS, Joosten S, Keith CD, Keller D, Khachatryan G, Khandaker M, Kim A, Kim W, Klein A, Klein FJ, Koirala S, Kubarovsky V, Kuhn SE, Lenisa P, Livingston K, Lu HY, MacGregor IJD, Markov N, Mayer M, McKinnon B, Meekins DG, Mineeva T, Mirazita M, Mokeev V, Montgomery R, Moody CI, Moutarde H, Movsisyan A, Munoz Camacho C, Nadel-Turonski P, Niculescu I, Osipenko M, Ostrovidov AI, Paolone M, Pappalardo LL, Park K, Park S, Pasyuk E, Peng P, Phelps W, Pogorelko O, Price JW, Prok Y, Protopopescu D, Puckett AJR, Ripani M, Rizzo A, Rosner G, Rossi P, Roy P, Sabatié F, Salgado C, Schott D, Schumacher RA, Senderovich I, Simonyan A, Skorodumina I, Sokhan D, Sparveris N, Stepanyan S, Stoler P, Strakovsky II, Strauch S, Sytnik V, Taiuti M, Tang W, Tian Y, Ungaro M, Voskanyan H, Voutier E, Walford NK, Watts DP, Wei X, Weinstein LB, Wood MH, Zachariou N, Zana L, Zhang J, Zonta I. Longitudinal target-spin asymmetries for deeply virtual compton scattering. PHYSICAL REVIEW LETTERS 2015; 114:032001. [PMID: 25658994 DOI: 10.1103/physrevlett.114.032001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2014] [Indexed: 06/04/2023]
Abstract
A measurement of the electroproduction of photons off protons in the deeply inelastic regime was performed at Jefferson Lab using a nearly 6 GeV electron beam, a longitudinally polarized proton target, and the CEBAF Large Acceptance Spectrometer. Target-spin asymmetries for ep→e^{'}p^{'}γ events, which arise from the interference of the deeply virtual Compton scattering and the Bethe-Heitler processes, were extracted over the widest kinematics in Q^{2}, x_{B}, t, and ϕ, for 166 four-dimensional bins. In the framework of generalized parton distributions, at leading twist the t dependence of these asymmetries provides insight into the spatial distribution of the axial charge of the proton, which appears to be concentrated in its center. These results also bring important and necessary constraints for the existing parametrizations of chiral-even generalized parton distributions.
Collapse
|
373
|
Gao M, Wei X, Li Y, Zhang S, Li X. Evaluation of primary thyroid lymphoma by ultrasonography combined with contrast-enhanced ultrasonography: A pilot study. Indian J Cancer 2015; 52:546-50. [DOI: 10.4103/0019-509x.178419] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
374
|
Wei X, Wu L, Huang S, Yang Q, Ren L, Huo Y. ASSA14-03-46 Inhibition of late sodium current reduces the reverse rate dependence of action potential duration prolongation induced by L-type calcium channel activator. BRITISH HEART JOURNAL 2015. [DOI: 10.1136/heartjnl-2014-307109.64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
375
|
Xu X, Li B, Wei X, Yang Y, Wang X, Chen Y. Differential expression of peroxisome proliferator-activated receptor γ, fatty acid synthase, and hormone-sensitive lipase in fat-tailed and thin-tailed sheep breeds. GENETICS AND MOLECULAR RESEARCH 2015; 14:15624-33. [DOI: 10.4238/2015.december.1.14] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|